全文获取类型
收费全文 | 38325篇 |
免费 | 3045篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 291篇 |
儿科学 | 1706篇 |
妇产科学 | 1184篇 |
基础医学 | 5185篇 |
口腔科学 | 401篇 |
临床医学 | 4651篇 |
内科学 | 7011篇 |
皮肤病学 | 681篇 |
神经病学 | 4513篇 |
特种医学 | 722篇 |
外科学 | 3710篇 |
综合类 | 353篇 |
现状与发展 | 1篇 |
一般理论 | 74篇 |
预防医学 | 5222篇 |
眼科学 | 596篇 |
药学 | 2504篇 |
中国医学 | 35篇 |
肿瘤学 | 2611篇 |
出版年
2024年 | 81篇 |
2023年 | 618篇 |
2022年 | 989篇 |
2021年 | 1951篇 |
2020年 | 1156篇 |
2019年 | 1674篇 |
2018年 | 1880篇 |
2017年 | 1271篇 |
2016年 | 1438篇 |
2015年 | 1494篇 |
2014年 | 1960篇 |
2013年 | 2459篇 |
2012年 | 3565篇 |
2011年 | 3448篇 |
2010年 | 1726篇 |
2009年 | 1483篇 |
2008年 | 2274篇 |
2007年 | 2364篇 |
2006年 | 1998篇 |
2005年 | 1832篇 |
2004年 | 1566篇 |
2003年 | 1293篇 |
2002年 | 1164篇 |
2001年 | 146篇 |
2000年 | 107篇 |
1999年 | 176篇 |
1998年 | 230篇 |
1997年 | 136篇 |
1996年 | 114篇 |
1995年 | 114篇 |
1994年 | 106篇 |
1993年 | 96篇 |
1992年 | 53篇 |
1991年 | 45篇 |
1990年 | 40篇 |
1989年 | 29篇 |
1988年 | 24篇 |
1987年 | 23篇 |
1986年 | 28篇 |
1985年 | 31篇 |
1984年 | 30篇 |
1983年 | 24篇 |
1982年 | 25篇 |
1981年 | 26篇 |
1980年 | 29篇 |
1979年 | 17篇 |
1978年 | 15篇 |
1977年 | 10篇 |
1974年 | 8篇 |
1972年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 16 毫秒
91.
92.
Maria Ruden Christopher H. Olivares Mathew Q. Fakhoury Alicia Roston Patricia P. Vidal Courtney M.P. Hollowell Sarah P. Psutka 《Urologic oncology》2021,39(1):73.e19-73.e25
PurposeTo compare the clinical presentation, treatment receipt, and oncologic outcomes between human immunodeficiency virus-seropositive (HIV+) and seronegative (HIV?) men with prostate cancer (CaP) matched by age, clinical stage, and race.Materials and methodsA retrospective review of 3,135 men treated for CaP from 2000 to 2016 was performed. HIV+ patients (N = 46) were matched 1:2 to 3 to HIV? men (N = 137) by age, race, and clinical stage. Clinicopathologic features and primary treatment received were compared between cohorts. Associations between HIV status and progression-free, cancer-specific, and overall survival were compared by HIV status using the Kaplan-Meier method and Cox proportional hazards analysis.ResultsAfter matching, men with and without HIV were similar with respect initial prostate-specific antigen, Gleason Sum, and Eastern Cooperative Oncology Group (ECOG) performance status. Among HIV+ men, 67.4% had a history of acquired immune deficiency syndrome, and 91.3% were on highly active antiretroviral therapy at CaP diagnosis. Among men with localized disease, HIV+ men were more likely to receive radiation (59.5% vs. 44.8%) or no therapy (13.5% vs. 4.3%) and less likely to receive surgery (16.2% vs. 30.2%), or to initiate active surveillance (10.8% vs. 16.4%; P = 0.04 overall). There were no differences in rates of clinical progression, development of castration resistance, or CaP death by HIV status. However, HIV+ status was associated with inferior overall survival (hazard ratio 2.89, P = 0.04).ConclusionsWhile most HIV+ patients had a history of acquired immune deficiency syndrome; HIV was well controlled in the majority of patients at the time of CaP diagnosis. While oncologic outcomes were similar between HIV+ and HIV? men, significant differences in treatment selection were observed. Further research is necessary to understand differences in treatment election by HIV status and to define optimal CaP treatment selection in men with HIV. 相似文献
93.
94.
95.
96.
Sarah Duncan-Park Claire Dunphy Jacqueline Becker Christine D’Urso Rachel Annunziato Joshua Blatter Carol Conrad Samuel B. Goldfarb Don Hayes Jr. Ernestina Melicoff Marc Schecter Gary Visner Brian Armstrong Hyunsook Chin Karen Kesler Nikki M. Williams Jonah N. Odim Stuart C. Sweet Lara Danziger-Isakov Eyal Shemesh 《American journal of transplantation》2021,21(9):3112-3122
Remote interventions are increasingly used in transplant medicine but have rarely been rigorously evaluated. We investigated a remote intervention targeting immunosuppressant management in pediatric lung transplant recipients. Patients were recruited from a larger multisite trial if they had a Medication Level Variability Index (MLVI) ≥2.0, indicating worrisome tacrolimus level fluctuation. The manualized intervention included three weekly phone calls and regular follow-up calls. A comparison group included patients who met enrollment criteria after the subprotocol ended. Outcomes were defined before the intent-to-treat analysis. Feasibility was defined as ≥50% of participants completing the weekly calls. MLVI was compared pre- and 180 days postenrollment and between intervention and comparison groups. Of 18 eligible patients, 15 enrolled. Seven additional patients served as the comparison. Seventy-five percent of participants completed ≥3 weekly calls; average time on protocol was 257.7 days. Average intervention group MLVI was significantly lower (indicating improved blood level stability) at 180 days postenrollment (2.9 ± 1.29) compared with pre-enrollment (4.6 ± 2.10), p = .02. At 180 days, MLVI decreased by 1.6 points in the intervention group but increased by 0.6 in the comparison group (p = .054). Participants successfully engaged in a long-term remote intervention, and their medication blood levels stabilized. NCT02266888. 相似文献
97.
Sarah Neu Humberto Vigil Jennifer A. Locke Sender Herschorn 《Canadian Urological Association journal》2021,15(3):E175
IntroductionWe aimed to evaluate the success of bladder neck injections of triamcinolone at the time of transurethral bladder neck incision (BNI) for prevention of recurrent vesicourethral anastomotic stenosis (VUAS) following prostate cancer treatment.MethodsThis is a retrospective cohort study examining patients with recurrent VUAS post-radical prostatectomy (RP) ± radiation treated with triamcinolone injections at the time of BNI. VUAS was diagnosed by symptoms followed by cystoscopy or urethrography. The outpatient procedures were done under general anesthesia. Cold knife incisions were made at the three, nine, and 12 o’clock BN positions, followed by triamcinolone injections (4 mg/mL) into the three and nine o’clock incision sites. Treatment outcomes were determined with cystoscopy.ResultsEighteen men underwent 25 procedures over a four-year period. Median age at diagnosis of VUAS was 65 (interquartile range [IQR] 61–68); median time to VUAS from RP was eight months (IQR 5–12). Fourteen patients (78%) had radiation treatment. The cohort had 128 unsuccessful VUAS treatments, with a median of five failed treatments per patient (IQR 3–10). Failed treatments included BN dilation, BNI, BN injection of mitomycin C, and urethral stent placement. Success rate after a mean of 16.3 months (standard deviation [SD] 8.1) from the time of triamcinolone injection was 83% (15/18). Six patients went on to have successful incontinence surgery. Five patients (28%) had treatment complications (bleeding, urinary tract infection, pain, and urinary extravasation). The three non-responders are stable and awaiting re-treatment with triamcinolone injection.ConclusionsTriamcinolone bladder neck injections for post-RP VUAS are a useful and safe treatment for recurrent stenosis. 相似文献
98.
Jane S Chen Mitch Matoga Brian W Pence Kimberly A Powers Courtney N Maierhofer Edward Jere Cecilia Massa Shiraz Khan Sarah E Rutstein Sam Phiri Mina C Hosseinipour Myron S Cohen Irving F Hoffman William C Miller Kathryn E Lancaster 《Journal of the International AIDS Society》2021,24(4)
IntroductionHIV diagnosis is the necessary first step towards HIV care initiation, yet many persons living with HIV (PLWH) remain undiagnosed. Employing multiple HIV testing strategies in tandem could increase HIV detection and promote linkage to care. We aimed to assess an intervention to improve HIV detection within socio‐sexual networks of PLWH in two sexually transmitted infections (STI) clinics in Lilongwe, Malawi.MethodsWe conducted a randomized controlled trial to evaluate an intervention combining acute HIV infection (AHI) screening, contract partner notification and social contact referral versus the Malawian standard of care: serial rapid serological HIV tests and passive partner referral. Enrolment occurred between 2015 and 2019. HIV‐seropositive persons (two positive rapid tests) were randomized to the trial arms and HIV‐seronegative (one negative rapid test) and ‐serodiscordant (one positive test followed by a negative confirmatory test) persons were screened for AHI with HIV RNA testing. Those found to have AHI were offered enrolment into the intervention arm. Our primary outcome of interest was the number of new HIV diagnoses made per index participant within participants’ sexual and social networks. We also calculated total persons, sexual partners and PLWH (including those previously diagnosed) referred per index participant.ResultsA total of 1230 HIV‐seropositive persons were randomized to the control arm, and 561 to the intervention arm. Another 12,713 HIV‐seronegative or ‐serodiscordant persons underwent AHI screening, resulting in 136 AHI cases, of whom 94 enrolled into the intervention arm. The intervention increased the number of new HIV diagnoses made per index participant versus the control (ratio: 1.9; 95% confidence interval (CI): 1.2 to 3.1). The intervention also increased the numbers of persons (ratio: 2.5; 95% CI: 2.0 to 3.2), sexual partners (ratio: 1.7; 95% CI: 1.4 to 2.0) and PLWH (ratio: 2.3; 95% CI: 1.7 to 3.2) referred per index participant.ConclusionsCombining three distinct HIV testing and referral strategies increased the detection of previously undiagnosed HIV infections within the socio‐sexual networks of PLWH seeking STI care. Combination HIV detection strategies that leverage AHI screening and socio‐sexual contact networks offer a novel and efficacious approach to increasing HIV status awareness. 相似文献
99.
Archives of Sexual Behavior - Adolescence is a critical time in the U.S. for religious development in that many young people eschew their religious identity as they enter adulthood. In general,... 相似文献
100.